Cue Biopharma announced the appointment of industry veteran Lucinda Warren as chief business officer. Most recently, she served as vice president of business development for Neuroscience and Japan Regionally at Johnson & Johnson from 2014 to 2024.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE:
- Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
- Cue Biopharma to present on CUE-401, CUE-100 series at conference
- Cue Biopharma price target lowered to $4 from $8 at Stifel
- Cue Biopharma reports Q2 EPS (20c), consensus (25c)
- Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights